Thorney Technologies Ltd Overview
Thorney Technologies is a small-cap Australian listed investment company that gives public-market investors exposure to a mixed portfolio of listed and unlisted technology and innovation businesses across all stages of the corporate lifecycle, from seed and pre-IPO rounds to established ASX small caps. It is externally managed by the private Thorney Investment Group of Alex Waislitz, which sources deal flow through networks in Australia, Israel and the United States and co-invests alongside TEK and its sister LIC, Thorney Opportunities (TOP). At 30 June 2026 the portfolio of roughly 60 positions was valued at AUD 71.4 million, split 53% listed, 38% unlisted and 9% cash. Five consecutive years of losses since FY2021 have cut after-tax NTA from 48.5c to 21.5c, and the shares trade at a persistent discount of around 50–60% to NTA. The current strategic agenda is portfolio simplification, on-market buy-backs and an independent Board review of manager performance.
Company's own description
According to the FY2026 Directors' Report, TEK's principal activity is investing in global, listed and unlisted technology investments at all phases of the investment lifecycle. Earlier annual reports (FY2022) describe a mandate to identify listed and unlisted companies with new and disruptive technology and business models, spanning fintech, e-commerce, education, agriculture, medical, telecommunications, robotics and AI. The monthly NTA reports describe TEK as an LIC with a broad technology mandate, managed by the privately owned Thorney Investment Group under a long-term investment management agreement, with the objective of generating absolute returns for shareholders over the medium to long term.
Independent characterisation
TEK functions as a closed-end, permanent-capital venture and small-cap growth vehicle. Economically it is a hybrid of three things:
-
An ASX micro/small-cap technology and healthcare activist-style equity portfolio (Level 1 listed equities of AUD 41.84 million at 30 June 2026, 53% of gross assets), concentrated in companies where the wider Thorney group (TIG + TEK + TOP) is frequently a substantial (>5%) holder.
-
A venture/private-equity book (Level 3 unlisted equities and loan notes of AUD 28.98 million, 37–39% of gross assets), including Australian and US/Israeli private companies (e.g., Splitit, Mosh, Elenium Automation, Updater, Roman Health Ventures, ConsenSys, Theator).
-
A small derivatives and cash sleeve (OTC options of AUD 0.58 million; cash of AUD 6.95 million at 30 June 2026; prime-broker facilities undrawn).
Business and revenue model
| Element | TEK model | Source |
|---|---|---|
| Revenue type | No product or service revenue. "Income" consists of net changes in fair value of investments (realised and unrealised), interest, dividends and minor other income | FY2026 AR, Note 3 |
| Income mix FY2026 | Net fair-value change -7.87m; interest 0.34m; dividends 0.06m; total investment loss -7.47m | FY2026 AR |
| Cost base | External management base fee (0.75% of gross assets per half-year, i.e., ~1.5% p.a.); performance fee 20% of increase above high-water mark (none paid since 1H FY2022); directors' fees; admin, legal and fund administration | FY2026 AR remuneration report |
| Capital model | Permanent capital raised via equity (AUD 36.6m FY2021; AUD 25.3m FY2022); no borrowings; capital returned via on-market buy-backs since FY2023 | FY2022, FY2024, FY2026 ARs |
| Dividend model | Profits reserve of AUD 237.2m preserved for future dividends, but no dividends paid in any year covered | FY2026 AR Note 11 |
| Value-chain position | Capital provider (seed to listed growth stage); frequently a board-level or substantial-holder engagement investor via the Thorney group | FY2026 AR; Dec 2024 NTA (Thorney representative on Dubber board from 1 Jan 2025) |
Customer types and end-markets
TEK's "customers" are its shareholders: 1,067 registered holders at 19 August 2026 (down from 1,576 at 16 August 2024), dominated by the Thorney/Waislitz interests (32.75%), Rubino Group (11.28%) and Janet Heather Cameron/Mutual Trust (9.61%) (FY2026 and FY2024 ARs). The underlying end-markets are those of its investees, principally: healthcare and medtech (Clarity, Imricor, Vitrafy, Avita, Mesoblast, Doctor Care Anywhere, Mosh, Microba, Amplia, Mach7, Visioneering); fintech and payments (Splitit, Credit Clear, Raiz, Plenti, QuickFee, FinClear, eToro, Swyftx, Touch Ventures); industrial and climate technology (Calix, Hazer, Red Earth Storage, DUG Technology, Elenium Automation); and software/consumer tech (Yojee, Spacetalk, Dubber, Beonic, Tinybeans, ReadCloud, Updater, Outdoorsy, Cargomatic, Traackr, Buildxact).
Strategy
Stated strategy (FY2026 Annual Report themes, paraphrased)
The FY2026 Chairman's letter (28 August 2026) articulates five themes:
-
Portfolio simplification — concentrating into a smaller number of higher-conviction holdings and liberating capital, on the view that a focused portfolio enables better capital allocation, deeper investee engagement and better long-term outcomes.
-
Capital preservation and risk management amid elevated rates, geopolitical conflict, tariffs and trade tensions.
-
Addressing the NTA discount — acknowledged as a source of shareholder frustration and a key Board priority; buy-backs at deep discounts are framed as accretive to continuing holders.
-
AI and digital infrastructure — identified as defining investment themes likely to shape capital allocation for years.
-
Opportunistic deployment — entering FY2027 with a simplified portfolio and financial flexibility to act on undervalued opportunities.
Strategic initiatives — last 24 months
| Initiative | Date | Detail / target | Status | Source |
|---|---|---|---|---|
| High-water-mark performance-fee mechanism | Effective 1 Jan 2024; HWM reset 31 Dec 2024 | Aligns fee with market practice; intended to help narrow discount | In force; no performance fee earned since | FY2024 and FY2026 ARs |
| On-market buy-back | Commenced 10 Oct 2024; extended 3 Nov 2025; expiry 13 Nov 2026 | Up to 31,045,455 shares; 22,182,414 bought by 8 Sep 2026 (8,863,041 remaining); broker UBS Securities Australia | Active; paused Mar–May 2025 to preserve cash | FY2026 AR; Kalkine buy-back notices |
| Portfolio simplification | FY2026 onward | Fewer positions; net realisations AUD 8.8m in FY2026; contract notes fell from 553 (FY2025) to 247 (FY2026) | Ongoing | FY2026 AR |
| IMA extension | 24 Feb 2026 | Seven-year extension of initial term to 16 Dec 2033 exercised by the Manager | Completed | ASX 24 Feb 2026 |
| Manager performance review | Announced 24 Feb 2026 | Independent Board sub-committee; Manager to undertake internal review and report back | Ongoing at 28 Aug 2026; no outcome published as at 18 Oct 2026 | ASX 24 Feb 2026; FY2026 AR |
| Board engagement in investees | From 1 Jan 2025 | Thorney representative appointed to Dubber board | In place | Dec 2024 NTA report |
| ESG / sustainability commitments | — | None articulated | — | — |
| Cost programme | — | No formal programme; fees decline mechanically with gross assets | — | — |
Medium-term targets / guidance
TEK provides no quantitative guidance, NTA targets, return targets, dividend targets or discount-narrowing targets. The FY2026 "Prospects" section states only that the Board expects attractive technology-focused opportunities to continue to emerge. The stated investment objective is absolute returns over the medium to long term (monthly NTA reports).
Products & Services
For an LIC, the "product" is a single listed security offering exposure to the investment portfolio. The economically relevant catalogue is therefore the portfolio of investee companies. The table below lists every holding disclosed in the FY2026 Annual Report (list of investments at 30 June 2026), in order of fair value, with a brief description of the investee's business. Descriptions are drawn from TEK filings where available (marked †) and otherwise from general public knowledge of the investee.
The TEK security (the "product")
| Attribute | Detail | Source |
|---|---|---|
| Instrument | Fully paid ordinary shares, one vote per share | FY2026 AR |
| Inception of current strategy | January 2017 | Monthly NTA reports |
| Management fee | 0.75% of gross asset value per half-year | FY2026 AR |
| Performance fee | 20% of increase in measurable portfolio above high-water mark, per half-year, net of base fee; HWM reset at 31 Dec 2024 | FY2026 AR |
| Return since inception | -0.05% p.a. (pre-tax, after fees, to 30 Sep 2026) | Sep 2026 NTA report |
| 3-year return | -5.51% p.a. (to 30 Sep 2026) | Sep 2026 NTA report |
| 1-year return | -20.08% (to 30 Sep 2026) | Sep 2026 NTA report |
Holdings at 30 June 2026 — listed investments
| Investee | Ticker | Fair value 30 Jun 2026 (AUD) | % gross assets | Business description |
|---|---|---|---|---|
| Vitrafy Life Sciences Ltd | VFY | 4,153,571 | 5.3 | Cryopreservation technology; listed since FY2024 (held as Pty Ltd shares and convertible notes at 30 Jun 2024) †; top positive contributor FY2026 † |
| Imricor Medical Systems, Inc | IMR | 3,405,486 | 4.3 | MRI-compatible cardiac ablation devices (US-domiciled, ASX-listed) |
| Clarity Pharmaceuticals Ltd | CU6 | 3,345,901 | 4.3 | Radiopharmaceuticals with multiple products under US FDA IND programs †; share price rose 600%+ in FY2024 † |
| Credit Clear Ltd | CCR | 3,119,875 | 4.0 | Digital debt-collection/receivables technology †; principal detractor FY2026 † |
| DUG Technology Ltd | DUG | 3,081,077 | 3.9 | High-performance computing and geoscience data services; positive contributor FY2026 † |
| Doctor Care Anywhere Group Plc | DOC | 2,828,210 | 3.6 | UK digital health/telehealth provider |
| Mesoblast Ltd | MSB | 2,397,496 | 3.0 | Allogeneic cell therapies |
| Yojee Ltd | YOJ | 2,341,500 | 3.0 | Logistics/transport management SaaS; detractor FY2026 † |
| Raiz Invest Ltd | RZI | 2,233,850 | 2.8 | Micro-investing and superannuation app |
| Spacetalk Ltd | SPA | 2,231,674 | 2.8 | Children's smartwatch/phone devices and services |
| Plenti Group Ltd | PLT | 1,974,370 | 2.5 | Consumer and green-energy lending fintech |
| Mach7 Technologies Ltd | M7T | 1,931,562 | 2.5 | Medical imaging data-management software; TEK became a substantial holder in FY2026 † |
| Calix Ltd | CXL | 1,588,750 | 2.0 | Multi-application mineral-processing technology targeting cement decarbonisation, agriculture and aquaculture †; positive contributor FY2026 † |
| Avita Medical Ltd | AVH | 1,499,084 | 1.9 | Skin-regeneration devices (RECELL) |
| Beonic Ltd | BEO | 1,133,068 | 1.4 | AI-driven customer/footfall analytics |
| Touch Ventures Ltd | TVL | 805,800 | 1.0 | Listed investment company in consumer/payments technology |
| eToro Group Ltd | ETOR | 780,303 | 1.0 | Global retail trading and investing platform (held as unlisted at 30 Jun 2024; listed by 30 Jun 2026) |
| Hazer Group Ltd | HZR | 769,355 | 1.0 | Low-emission hydrogen and graphite from methane |
| QuickFee Ltd | QFE | 767,104 | 1.0 | Payment and financing solutions for professional-services fees; positive contributor FY2026 † |
| Amplia Therapeutics Ltd | ATX | 744,702 | 0.9 | Clinical-stage oncology (FAK inhibitor) |
| Dubber Corporation Ltd | DUB | 653,815 | 0.8 | Cloud call-recording and voice-data platform †; Thorney representative appointed to DUB board 1 Jan 2025 † |
| Tinybeans Group Ltd | TNY | 590,802 | 0.8 | Family photo-sharing and parenting platform |
| ReadCloud Ltd | RCL | 577,850 | 0.7 | eLearning and digital textbooks for schools |
| Microba Life Sciences Ltd | MAP | 461,317 | 0.6 | Microbiome testing and therapeutics (two line items: 459553 and 1764) |
| Terragen Holdings Ltd | TGH | 404,728 | 0.5 | Agricultural biologicals; TEK ceased to be substantial holder FY2026 † |
| Rare Foods Australia Ltd | — | 35,918 | 0.0 | Wild-harvest seafood (listed in FY2024; shown without ticker FY2026) |
| Total listed | — | 41,843,158 | 53.2 | FY2026 AR |
Holdings at 30 June 2026 — unlisted investments
| Investee | Fair value 30 Jun 2026 (AUD) | % gross assets | Business description |
|---|---|---|---|
| Splitit Payments Ltd | 4,843,838 | 6.2 | Instalment payments using customers' existing credit cards; largest single holding |
| Mosh | 3,534,176 | 4.5 | Australian online men's health and wellness platform (raised AUD 26m pre-IPO in Dec 2021 †); positive contributor FY2026 † |
| Red Earth Storage Ltd | 2,115,231 | 2.7 | Residential battery energy storage (as named in filings) |
| 360 Capital Fibreconx Trust | 2,044,924 | 2.6 | Fibre-network infrastructure trust |
| Elenium Automation Ltd | 1,956,136 | 2.5 | Airport and travel passenger-processing automation (held via convertible preference shares at 30 Jun 2024 †) |
| WSC Technologies | 1,514,637 | 1.9 | Business not described in TEK filings |
| Visioneering Technologies Inc. | 1,155,928 | 1.5 | Myopia-management contact lenses (formerly ASX: VTI; now unlisted) |
| FinClear Holdings Pty Ltd | 1,061,571 | 1.3 | Market infrastructure, clearing and wealth technology |
| Proto Inc | 796,081 | 1.0 | Holographic display/communications hardware |
| SH2 Holdings Pty Ltd | 791,181 | 1.0 | Business not described in TEK filings |
| BikeExchange Ltd | 635,756 | 0.8 | Online cycling marketplace (formerly ASX-listed) |
| Adacel Technologies Ltd | 602,400 | 0.8 | Air-traffic management and simulation software (formerly ASX: ADA) |
| HiFi Labs | 538,679 | 0.7 | Held via SAFE in FY2024 †; business not described in TEK filings |
| Updater Inc. | 518,401 | 0.7 | US home-relocation app; formerly TEK's largest unlisted investment † |
| Awayco Holdings Pty Ltd | 491,756 | 0.6 | Business not described in TEK filings |
| Packform Pty Ltd | 480,375 | 0.6 | Business not described in TEK filings |
| 58 Jarque Pty Ltd | 441,467 | 0.6 | Wholly owned investment subsidiary † |
| Worthy Inc. | 363,973 | 0.5 | US fintech; detractor FY2026 † |
| BabyQuip Inc. | 363,972 | 0.5 | US baby-gear rental marketplace |
| GLX Holdings Ltd | 355,615 | 0.5 | Business not described in TEK filings |
| Roman Health Ventures Inc. | 315,560 | 0.4 | US direct-to-consumer telehealth (Ro) |
| Outdoorsy | 291,178 | 0.4 | US RV and campervan rental marketplace |
| Swyftx Pty Ltd | 285,157 | 0.4 | Australian cryptocurrency exchange |
| Cargomatic Inc | 279,361 | 0.4 | US local trucking/freight marketplace |
| Buildxact Software Ltd | 269,859 | 0.3 | Construction estimating and job-management software |
| Traackr | 262,276 | 0.3 | Influencer-marketing analytics platform |
| Visual Amplifiers Holdings Pty Ltd | 235,568 | 0.3 | Business not described in TEK filings |
| Whizz Technologies Pty Ltd | 201,431 | 0.3 | Business not described in TEK filings |
| ConsenSys | 189,330 | 0.2 | Ethereum blockchain software |
| Theator Inc. | 184,971 | 0.2 | Surgical video AI |
| Brainvivo | 145,589 | 0.2 | Business not described in TEK filings |
| Pogoseat Inc | 145,589 | 0.2 | Business not described in TEK filings |
| Carbon Growth Opportunities Fund | 87,353 | 0.1 | Carbon/climate-focused fund |
| GOARC | 39,618 | 0.1 | Held via SAFE in FY2024 † |
| Viably Capital Inc | 7,731 | 0.0 | Business not described in TEK filings |
| Total unlisted (incl. derivatives) | 29,560,678 | 37.6 | FY2026 AR |
Totals at 30 June 2026: investments AUD 71,403,836 (90.8% of gross assets); cash AUD 6,945,798 (8.8%); other assets AUD 318,277 (0.4%); gross assets AUD 78,667,911 (FY2026 AR).
Portfolio evolution — notable additions and exits
| Holding | 30 Jun 2024 status | 30 Jun 2026 status | Comment | Source |
|---|---|---|---|---|
| Clarity Pharmaceuticals | 15.56m, 14.9% of gross assets (largest) | 3.35m, 4.3% | Significant profits realised in FY2024 | FY2024 and FY2026 ARs |
| Calix | 5.68m, 5.4% | 1.59m, 2.0% | Negative in FY2024; positive contributor FY2026 | FY2024 and FY2026 ARs |
| Life360 | 2.89m, 2.8% | Not held | Exited | FY2024 and FY2026 ARs |
| Imugene, BrainChip, Micro-X, Next Science, Xref, Envirosuite, Felix, Banxa, Spirit, Pentanet, Radiopharm, Sovereign Cloud, Chimeric, FiscalNote, Carbon Revolution, ARBE | Held | Not in FY2026 list | Exited or written to nil | FY2024 and FY2026 ARs |
| Nexdius Pty Ltd | 1.29m | Not in list | Principal detractor FY2026 | FY2024 and FY2026 ARs |
| Daisee Pty Ltd | 0.92m | Not in list | Detractor FY2026 | FY2024 and FY2026 ARs |
| Vitrafy Life Sciences | 1.00m (equity plus notes) | 4.15m | Largest listed holding by Sep 2026 (7.9%) | FY2024, FY2026 ARs; Sep 2026 NTA |
| Splitit Payments | 2.21m | 4.84m | Largest holding | FY2024 and FY2026 ARs |
| Mosh | 2.00m | 3.53m | Uplift | FY2024 and FY2026 ARs |
| Imricor | 0.79m | 3.41m | Uplift and/or additions | FY2024 and FY2026 ARs |
| Mesoblast | 1.68m | 2.40m | Increased | FY2024 and FY2026 ARs |
| Yojee | 0.27m | 2.34m | Increased, then detractor | FY2024 and FY2026 ARs |
Most recent top holdings (30 September 2026)
| Rank | Listed holding | % portfolio | Unlisted holding | % portfolio |
|---|---|---|---|---|
| 1 | Vitrafy Life Sciences (VFY) | 7.9 | Splitit Payments | 6.7 |
| 2 | Clarity Pharmaceuticals (CU6) | 4.4 | Mosh | 4.9 |
| 3 | Imricor Medical Systems (IMR) | 4.0 | 360 Capital Fibreconx | 2.8 |
| 4 | Doctor Care Anywhere (DOC) | 3.8 | Elenium Automation | 2.7 |
| 5 | Credit Clear (CCR) | 3.6 | WSC Technologies | 2.1 |
Source: Sep 2026 NTA report (via Kalkine). Allocation at 30 Sep 2026: 56% listed, 35% unlisted, 9% cash.
Financial Narrative
All figures AUD million unless stated; fiscal years ending 30 June. FY2022 from FY2022 AR; FY2023–FY2024 from FY2024 AR; FY2025–FY2026 from FY2026 AR. Conventional operating metrics (gross profit, EBITDA, capex) are not applicable to an LIC; the closest equivalents are shown and labelled.
Income statement
FY2021 reference: total investment income AUD 79.87m; total expenses AUD 17.71m (incl. performance fees AUD 14.07m); net profit AUD 52.85m; EPS 16.7c (FY2022 AR).
Margins. Because total investment income is negative in four of five years, gross, operating, EBITDA and net margins are not meaningful (n/m) for FY2022, FY2023, FY2024 and FY2026. For FY2025 only: pre-tax margin 12.1% (0.34/2.82) and net margin -165% (-4.66/2.82), the latter distorted by a AUD 5.00m deferred-tax charge. Revenue CAGR FY2022–FY2026 is n/m (sign changes).
Commentary. The income statement is a mark-to-market ledger. FY2022's AUD 84.1m unrealised loss marked the unwinding of the 2020–21 technology bubble; TEK still realised AUD 23.6m of gains that year and paid a AUD 1.9m performance fee for 1H FY2022 before the drawdown. FY2023–FY2024 losses were driven by listed small-cap de-ratings and, in FY2024, by approximately AUD 8.3m of prudent unlisted fair-value adjustments plus AUD 4.5m of unlisted assets written off at cost (FY2024 AR Chairman's letter and Note 6). FY2025 was the only year near break-even at the pre-tax line (AUD 0.34m), helped by AUD 1.2m of interest income. FY2026 presents an important composition shift: realised losses of AUD 18.9m (crystallising losses on exited positions as part of portfolio simplification) were partly offset by AUD 11.0m of unrealised gains on retained holdings (Vitrafy, DUG, QuickFee, Mosh, Calix). The AUD 6.70m tax charge reflects the full derecognition of the remaining deferred tax asset, taking the after-tax loss to AUD 16.4m. The expense base has been almost halved since FY2022 (excluding performance fees) because base fees scale with a shrinking gross asset value; however, the fixed-cost element means the expense ratio has crept up from 2.07% to 2.55%.
Balance sheet
Notes: "Short-term debt" in FY2024 is AUD 152,569 due to custodians and in FY2026 AUD 217,534 due to prime broker (operational settlement balances, not borrowings); TEK states it has no borrowings (FY2026 AR Note 17).
Equity reserves (30 Jun 2026): issued capital AUD 107.20m; profits reserve AUD 237.18m; accumulated losses AUD -266.81m (FY2026 AR). The profits reserve keeps growing (AUD 19.48m transferred in FY2026) even as total equity shrinks, because transfers are made from current-year profits on a per-entity basis that differs from the consolidated P&L presentation; the reserve is notionally available for dividends but no dividend policy has been articulated.
Tax losses: unrecognised tax losses of AUD 24.79m (tax-effected) at 30 June 2026; estimated unused gross revenue tax losses of AUD 99.1m (FY2025: AUD 78.6m; FY2024 AR disclosed AUD 135.1m — the FY2024-to-FY2025 reduction is not explained in the extracts reviewed) (FY2026 and FY2024 ARs, Note 5).
Commentary. TEK's balance sheet is debt-free and liquid at the listed level. The key balance-sheet events are (1) the steady contraction of net assets from AUD 175.5m (FY2021) to AUD 77.6m (FY2026), a 56% decline driven by losses (~AUD 113m cumulative FY2022–FY2026) and buy-backs (AUD 9.0m cumulative FY2023–FY2026), partly offset by the AUD 24.5m net raise in FY2022; and (2) the progressive write-off of the deferred tax asset, from AUD 19.1m (FY2022–FY2023) to nil (FY2026). The DTA derecognition means after-tax NTA now equals pre-tax NTA, removing a soft asset from book value; it also means any future realised gains can be sheltered by ~AUD 99m of gross revenue losses (subject to statutory tests), a latent value that is not on the balance sheet.
Cash flow statement
Sources: FY2022, FY2024, FY2026 ARs, statements of cash flows. Note: TEK classifies purchases/sales of its trading portfolio within operating cash flow and its long-term portfolio within investing cash flow, so "operating cash flow" for an LIC is primarily a measure of net portfolio realisation rather than recurring earnings. FY2025 buy-back cash outflow includes AUD 1,559 of costs (AUD 2.718m total).
Commentary. In FY2026 TEK was a net seller: trading sales of AUD 16.3m vs purchases of AUD 7.5m, no long-term investment, and AUD 1.9m spent on buy-backs, lifting cash from AUD 2.2m to AUD 6.9m. This is consistent with the stated "liberating capital" strategy. Recurring cash costs ("payments to suppliers") of ~AUD 2.5m p.a. against cash interest and dividends of only ~AUD 0.27m mean TEK must realise ~AUD 2.2m of investments each year simply to fund operations — roughly 3% of the portfolio.
Ratios
Calculated from audited figures (FY2021 opening equity AUD 175.55m and total assets AUD 187.74m from FY2022 AR). Not applicable / not meaningful: net debt/EBITDA (net cash, negative EBITDA), interest coverage (finance costs of AUD 0–2.4k), asset turnover (negative income), cash conversion cycle (no inventory, receivables or trade payables in the operating sense).
Trend synthesis. The five-year record is uniformly negative on return metrics: compounded NTA per share after tax fell from 36.4c to 21.5c (-41%, roughly -10.0% p.a.). The FY2025 "inflection" proved temporary. Positives are structural rather than performance-based: no leverage, high liquidity in the listed book, a falling absolute fee bill, and an accretive buy-back executed at an average 10.95c in FY2026 against NTA of ~21–26c.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Country | Ownership | Status / role | Source |
|---|---|---|---|---|
Thorney Technologies Ltd | Australia | Parent | Listed investment entity | FY2026 AR |
58 Jarque Pty Ltd | Australia | 100% | Investment-holding subsidiary; fair value AUD 441467 at 30 Jun 2026 | FY2026 AR Notes 19, list of investments |
AR Fuels US LLC | USA | 100% | Dormant legacy subsidiary (tax resident in Australia) | FY2026 AR |
Biodiesel Producers Pty Ltd | Australia | — | Deregistered FY2022 | FY2022 AR |
Australian Renewable Fuels Adelaide Pty Ltd | Australia | — | Deregistered FY2022 | FY2022 AR |
Income component (AUD Mn)
| Income component (AUD Mn) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Net realised gain or loss on investments | 23.62 | -3.46 | -3.30 | -1.78 | -18.91 |
Unrealised gain or loss on investments | -84.10 | -20.09 | -9.60 | 3.36 | 11.04 |
Net change in fair value of investments | -60.48 | -23.54 | -12.89 | 1.58 | -7.87 |
Interest income | 0.47 | 0.69 | 1.11 | 1.20 | 0.34 |
Dividend income | 0.11 | 0.30 | 0.07 | 0.00 | 0.06 |
Other income | 0.01 | 0.00 | 0.02 | 0.05 | 0.00 |
Total investment income (loss) | -59.90 | -22.55 | -11.70 | 2.82 | -7.47 |
Asset class (AUD Mn)
| Asset class (AUD Mn) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Level 1 listed equities | 76.69 | 59.77 | 61.20 | 54.33 | 41.84 |
Level 2 OTC derivatives | 0.00 | 0.00 | 0.00 | 1.36 | 0.58 |
Level 3 unlisted equities and loan notes | 50.16 | 36.63 | 27.09 | 31.61 | 28.98 |
Total financial assets | 126.85 | 96.40 | 88.29 | 87.29 | 71.40 |
Cash | 9.33 | 12.83 | 3.19 | 2.24 | 6.95 |
Revenue by Segment (%)
| Mix (% of total financial assets) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Listed share (%) | 60.5 | 62.0 | 69.3 | 62.2 | 58.6 |
Unlisted share (%) | 39.5 | 38.0 | 30.7 | 36.2 | 40.6 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansRevenue by Segment
| Level 3 by industry (AUD Mn) | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
Information technology and services | 23.68 | 26.85 | 18.13 | 9.34 |
FinTech and e-commerce | 10.23 | 7.80 | 6.07 | 8.66 |
Entertainment and media | 0.79 | 2.56 | 2.78 | 2.71 |
Health care technology | 2.70 | 6.41 | 4.19 | 4.07 |
Consumer and industrial products | 2.60 | 6.47 | 5.43 | 2.30 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansIncome Statement and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total investment income ("revenue" proxy, AUD Mn) | -59.90 | -22.55 | -11.70 | 2.82 | -7.47 |
Gross profit (AUD Mn, equals total investment income; no cost of sales) | -59.90 | -22.55 | -11.70 | 2.82 | -7.47 |
Management fees (AUD Mn) | 2.93 | 2.16 | 1.71 | 1.61 | 1.37 |
Performance fees (AUD Mn) | 1.92 | 0.00 | 0.00 | 0.00 | 0.00 |
Directors' fees (AUD Mn) | 0.21 | 0.23 | 0.23 | 0.23 | 0.19 |
Legal and professional fees (AUD Mn) | 0.44 | 0.37 | 0.45 | 0.32 | 0.36 |
Fund administration and operational costs (AUD Mn) | 0.19 | 0.11 | 0.12 | 0.22 | 0.21 |
Other administrative expenses (AUD Mn) | 0.10 | 0.10 | 0.11 | 0.10 | 0.10 |
Total expenses (AUD Mn) | 5.78 | 2.97 | 2.62 | 2.48 | 2.24 |
Operating income = pre-tax result (AUD Mn) | -65.68 | -25.52 | -14.32 | 0.34 | -9.71 |
EBITDA proxy (pre-tax plus finance costs, AUD Mn) | -65.68 | -25.52 | -14.32 | 0.34 | -9.71 |
Income tax benefit or expense (AUD Mn) | 20.53 | 0.00 | -7.40 | -5.00 | -6.70 |
Net profit or loss (AUD Mn) | -45.15 | -25.52 | -21.72 | -4.66 | -16.41 |
EPS basic (AUD cents) | -10.7 | -6.0 | -5.3 | -1.2 | -4.4 |
EPS diluted (AUD cents) | -10.7 | -6.0 | -5.3 | -1.2 | -4.4 |
Dividends per share (AUD cents) | 0 | 0 | 0 | 0 | 0 |
Weighted average shares (millions) | 421.86 | 424.69 | 408.08 | 384.50 | 374.95 |
Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total expense ratio (%) | 3.36 | 2.07 | 2.23 | 2.46 | 2.55 |
Management fee ratio (%) | 1.70 | 1.50 | 1.46 | 1.60 | 1.56 |
Balance Sheet and Share Count (millions)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (AUD Mn) | 156.45 | 130.37 | 104.48 | 96.93 | 78.67 |
Cash and equivalents (AUD Mn) | 9.33 | 12.83 | 3.19 | 2.24 | 6.95 |
Financial assets at fair value (AUD Mn) | 126.85 | 96.40 | 88.29 | 87.29 | 71.40 |
Deferred tax asset (AUD Mn) | 19.10 | 19.10 | 11.70 | 6.70 | 0.00 |
Short-term debt (AUD Mn) | 0.00 | 0.00 | 0.15 | 0.00 | 0.22 |
Long-term debt (AUD Mn) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total debt (AUD Mn) | 0.00 | 0.00 | 0.15 | 0.00 | 0.22 |
Net debt (AUD Mn, negative = net cash) | -9.33 | -12.83 | -3.04 | -2.24 | -6.73 |
Total liabilities (AUD Mn) | 1.59 | 2.19 | 1.26 | 1.08 | 1.10 |
Total equity = net assets (AUD Mn) | 154.86 | 128.18 | 103.23 | 95.85 | 77.57 |
Goodwill and intangibles (AUD Mn) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Working capital (AUD Mn) | 94.17 | 79.28 | 68.84 | 56.06 | 48.18 |
Shares on issue (millions) | 425.04 | 418.10 | 397.79 | 377.83 | 360.82 |
NTA per share after tax (AUD cents) | 36.4 | 30.7 | 25.9 | 25.4 | 21.5 |
NTA per share before tax (AUD cents) | 31.9 | 26.1 | 23.0 | 23.6 | 21.5 |
Cash Flow
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating cash flow (AUD Mn) | -12.51 | 11.04 | -5.51 | 4.60 | 6.57 |
of which proceeds from sale of trading investments (AUD Mn) | 51.66 | 23.94 | 11.49 | 23.13 | 16.27 |
of which payments for trading investments (AUD Mn) | -49.76 | -11.40 | -14.64 | -16.54 | -7.47 |
Investing cash flow (AUD Mn) | -9.15 | -6.39 | -1.04 | -2.66 | 0.00 |
Capex (AUD Mn, not applicable) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free cash flow, OCF less capex (AUD Mn) | -12.51 | 11.04 | -5.51 | 4.60 | 6.57 |
OCF plus investing cash flow (AUD Mn) | -21.66 | 4.65 | -6.56 | 1.94 | 6.57 |
Equity raised, gross (AUD Mn) | 25.30 | 0.00 | 0.00 | 0.00 | 0.00 |
Share buy-backs (AUD Mn) | 0.00 | 1.16 | 3.24 | 2.72 | 1.86 |
Dividends paid (AUD Mn) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net change in cash (AUD Mn) | 2.81 | 3.50 | -9.64 | -0.93 | 4.71 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE on average equity (%) | -27.3 | -18.0 | -18.8 | -4.7 | -18.9 |
ROA on average assets (%) | -26.2 | -17.8 | -18.5 | -4.6 | -18.7 |
ROIC (%, equal to ROE as no debt) | -27.3 | -18.0 | -18.8 | -4.7 | -18.9 |
Current ratio (x) | 60.2 | 37.2 | 55.7 | 52.7 | 45.0 |
Debt to equity (x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NTA per share change (%) | -24.9 | -15.7 | -15.6 | -1.9 | -15.4 |
Assets by currency (AUD Mn)
| Assets by currency (AUD Mn) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
USD-denominated assets | 33.13 | 22.74 | 11.33 | 10.05 | 6.96 |
CAD-denominated assets | 2.01 | 1.45 | 0.86 | 1.82 | 0.00 |
AUD and other unexposed assets | 121.31 | 106.18 | 92.29 | 85.06 | 71.71 |
Total assets | 156.45 | 130.37 | 104.48 | 96.93 | 78.67 |
Growth (%)
| Growth (%) | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
USD assets YoY (%) | -31.4 | -50.2 | -11.3 | -30.7 |
CAD assets YoY (%) | -27.9 | -40.7 | 111.6 | -100.0 |
AUD assets YoY (%) | -12.5 | -13.1 | -7.8 | -15.7 |
Per-Share Data and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Share price at 30 June (AUD cents) | 21.0 | 17.5 | 12.5 | 9.5 | 9.0 |
NTA per share after tax (AUD cents) | 36.4 | 30.7 | 25.9 | 25.4 | 21.5 |
Discount to after-tax NTA (%) | 42.3 | 43.0 | 51.7 | 62.6 | 58.1 |
Shares on issue (millions) | 425.04 | 418.10 | 397.79 | 377.83 | 360.82 |
Market cap at 30 June (AUD Mn) | 89.26 | 73.17 | 49.72 | 35.89 | 32.47 |
Shares bought back in year (millions) | 0.00 | 6.95 | 20.31 | 19.95 | 17.01 |
Buy-back spend (AUD Mn) | 0.00 | 1.16 | 3.24 | 2.72 | 1.86 |
Average buy-back price (AUD cents) | 0.00 | 16.64 | 15.95 | 13.62 | 10.95 |
Share Price History
| Period | Start price (AUD cents) | End price (AUD cents) | Change (%) | Basis |
|---|---|---|---|---|
1-year (30 Jun 2025 to 30 Jun 2026) | 9.5 | 9.0 | -5.3 | FY2026 AR table (see discrepancy note) |
3-year (30 Jun 2023 to 30 Jun 2026) | 17.5 | 9.0 | -48.6 | FY2026 AR table |
5-year (30 Jun 2021 to 30 Jun 2026) | 43.0 | 9.0 | -79.1 | FY2022 and FY2026 ARs |
Current vs 30 Jun 2026 | 9.0 | 10.5 | 16.7 | Sep 2026 NTA; StockInvest.us |
52-week range | 8.8 | 14.5 | — | Investing.com (as of 5 Oct 2026) |
Relative to ASX 200 (1-year, date not specified) | — | — | -29.89 pts | Market Index |
Valuation Multiples
| Multiple | TEK | Notes |
|---|---|---|
Price / NTA (x) | 0.51 | 10.5c / 20.7c |
Price / book (x) | 0.51 | NTA equals book value (no intangibles, no DTA) |
P/E | n/m | Loss-making |
EV / EBITDA | n/m | Negative EBITDA |
EV / Sales | n/m | Negative total investment income |
Enterprise value (AUD Mn) | ~30.8 | Market cap 37.0 less cash 6.2 (calculated); Yahoo Finance shows -31.76m, which appears to treat listed investments as cash-like |
Peer P/NTA: BTI (x) | 0.58 | 42% discount at 30 Jun 2026 |
Peer P/NTA: TOP (x) | 0.66 | 57.0c / 86.7c at 31 Jul 2026 (calculated) |
Capital Markets
| Item | Status | Source |
|---|---|---|
Analyst consensus / price targets | None; no broker coverage identified (MarketBeat shows no consensus or target) | MarketBeat |
Technical rating (non-fundamental) | StockInvest.us "Buy Candidate", technical score 2.50 (15 Oct 2026); TipRanks technical signal "Strong Sell" (Oct 2026) — conflicting, low-value signals | StockInvest.us; TipRanks |
Dividend history | No dividends paid or declared in any year reviewed (FY2017 to FY2026) | FY2022–FY2026 ARs |
Dividend policy | None stated; profits reserve AUD 237.2m "preserved for future dividend payments" | FY2026 AR Note 11 |
Buy-back authorisation | Up to 31,045,455 shares; 8,863,041 remaining at 8 Sep 2026 (before ~5m further Sep purchases); expires 13 Nov 2026 | Kalkine; FY2026 AR |
Credit ratings (Moody's / S&P / Fitch) | None — no rated debt | — |
Debt maturity profile | Not applicable — no borrowings | FY2026 AR Note 17 |
Analyst Conclusions
Management guidance and consensus
Management provides no quantitative guidance. Qualitatively, the Board expects attractive technology opportunities to continue to emerge, intends to keep simplifying the portfolio and to continue buy-backs, and remains optimistic about AI- and digital-infrastructure-driven opportunities (FY2026 AR). There is no sell-side consensus.
Bull case
-
Asset-backed discount with accretive self-help. At 10.5c the market values TEK at ~51% of an NTA that is now "clean" (no DTA, no debt). Each buy-back tranche at ~10.5c is roughly 2x accretive, and the remaining authority plus a likely renewal could retire another 5–10% of shares.
-
Concentrated winners and realisation optionality. Vitrafy, Splitit and Mosh together account for ~19.5% of the portfolio (Sep 2026); a liquidity event in Splitit or Mosh at or above carrying value would both validate the unlisted marks and crystallise cash, and ~AUD 99m of gross tax losses means gains would largely accrue to NTA untaxed.
-
Governance catalyst. The independent sub-committee review (Feb 2026), rising Thorney ownership (32.9%) and a 10.26% protest vote create conditions for structural action — e.g., fee changes, a dividend from the AUD 237m profits reserve, or a capital-return mechanism — that could close part of the discount.
Bear case
-
Track record. Since-inception returns are ~0% p.a. after nine years, three-year returns are -5.5% p.a., and NTA has fallen in four of the last five years; there is little evidence the strategy generates alpha in its current form.
-
Entrenchment and value leakage. The Manager has extended the IMA to 2033; Thorney controls ~33% of votes, limiting shareholders' ability to force change. Fixed costs (~AUD 2.2m p.a.) are a rising share of a shrinking asset base and are funded by forced realisations.
-
Valuation risk in the unlisted book. ~35–39% of the portfolio is Level 3, valued largely on investee-supplied information; FY2024 write-offs of AUD 4.5m and FY2026 unlisted write-downs of AUD 3.6m show marks can fall abruptly. The market's 50% discount may partly reflect scepticism about these values.
Catalysts and monitorables — next 12 months
| Date / timing | Catalyst | What to watch |
|---|---|---|
| ~10–14 Nov 2026 | October 2026 NTA | Trend vs 20.7c; buy-back volume |
| 13 Nov 2026 | Buy-back expiry | Renewal and size of new authority |
| 17 Nov 2026 | 2026 AGM | Remuneration-report vote (two-strikes threshold is 25%); any update on sub-committee review; board renewal / independent appointments |
| Any time | Sub-committee review outcome | Fee restructuring, dividend initiation, manager change, wind-up or merger proposals (none announced) |
| Late Feb 2027 | 1H FY2027 Appendix 4D | Realised vs unrealised mix; Level 3 movements |
| Ongoing | Unlisted liquidity events | Splitit, Mosh, Elenium, Red Earth Storage, FinClear |
| Ongoing | Thorney stake | Creep above 35%+ (no takeover-threshold issue until 20% under creep rules, which have already been exceeded — mechanism used is the 3% per six months creep exception or buy-back-driven increase; method not disclosed) |
| Late Aug 2027 | FY2027 results | Whether the five-year loss streak is broken |
Concluding analyst verdict
Thorney Technologies is best understood not as a technology company but as a small, externally managed, deeply discounted closed-end fund whose investment case now rests almost entirely on capital management and governance rather than on demonstrated investment skill. The numbers are unambiguous: after-tax NTA has fallen from 48.5c in FY2021 to 20.7c in September 2026, net losses have totalled AUD 113.5m over five years, and the since-inception pre-tax return to September 2026 is essentially zero. Peers such as Bailador have delivered positive returns and dividends through the same tech downturn, which undermines any argument that TEK's results are purely cyclical.
Against that, the balance sheet has become cleaner and more conservative. The deferred tax asset is gone, there is no debt, cash has tripled to ~AUD 6–7m, the portfolio is being concentrated, and buy-backs at around half of NTA are genuinely accretive. The holdings contain real assets — Vitrafy, Clarity, Imricor, Splitit and Mosh — whose realisation could move NTA meaningfully, and the ~AUD 99m tax-loss pool would shelter gains.
The pivotal variable is the Board sub-committee review launched in February 2026, set against the Manager's simultaneous extension of its mandate to 2033 and Thorney's rising 32.9% stake. If the review yields concrete discount-narrowing measures — a dividend from the AUD 237m profits reserve, a fee reduction, a tender or a structured exit — the 50% discount offers substantial upside without requiring any improvement in markets. If it does not, the shares are likely to remain a value trap, with fixed costs and buy-backs gradually shrinking the vehicle while the controlling holder's influence grows.
Verdict: a special-situations discount play. Key monitorable: the 17 November 2026 AGM.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Role | Appointed | Background | Source |
|---|---|---|---|---|
Craig Smith, B.Bus (Acct), GIA (Cert) | Company Secretary | 22 Jun 2016 | Company secretary of private Thorney Investment Group since 2009 and of Thorney Opportunities since 2013; director and company secretary of Anaeco; former CFO/company secretary of Baxter Group and Tolhurst Noall; TEK director during 2016 recapitalisation | FY2026 AR |
Thorney Management Services Pty Ltd | Investment Manager (KMP) | IMA from Dec 2016/Jan 2017; extended to 16 Dec 2033 | AFSL 444369; subsidiary of Thorney Investment Group Australia | FY2026 AR; ASX 24 Feb 2026 |
Board of Directors
| Name | Title | Director since | Tenure (years) | Education | Prior / other roles | Source |
|---|---|---|---|---|---|---|
Alex Waislitz OAM | Non-Executive Chairman | 9 Dec 2016 | 9.9 | BEc, LLB (Monash); Harvard Business School OPM | Founder and Chairman of Thorney Investment Group; Chairman of Thorney Opportunities; co-owner of Australian Community Media (160+ regional publications); Collingwood FC Vice President for 20+ years to 2021; founder of Waislitz Foundation and Waislitz Family Foundation; OAM June 2023 | FY2026 AR |
Jeremy Leibler | Non-Executive Director | 9 Dec 2016 | 9.9 | BComm, LLB (Hons) | Partner, Arnold Bloch Leibler (M&A, capital raisings, activism, board disputes); third term on Australian Takeovers Panel; Corporations Committee, Law Council of Australia; Governor, Hebrew University of Jerusalem | FY2026 AR |
Alan Fisher | Non-Executive Director; Chair of Audit & Risk Committee | 29 Aug 2014 | 12.1 | BCom (Melbourne); FCA; MAICD | Chair of TEK to Dec 2016; NED and Chair of Neuphoria Therapeutics Inc (formerly Bionomics); former NED of IDT Australia and Centrepoint Alliance | FY2026 AR |
Martin Casey | Non-Executive Director; ARC member from 2 Jul 2026 | 22 Jun 2016 | 10.3 | BEc, LLB (Monash) | Chief of Staff, Waislitz Family Office (from early 2022); long-term adviser to TIG; partner in Rampersand (tech VC); director of Fortlake Asset Management, Anaeco, ADG Global; former partner at an international law firm and investment banker at Credit Suisse | FY2026 AR |
Tim Birch (former) | Non-Executive Director | 8 Nov 2021 – 17 Nov 2025 | 4.0 | — | Ex-APAC Regional VP Salesforce; ex-Vietnam Country Manager Apple; Partnerships at Stripe | FY2024 and FY2026 ARs |
“—” = not publicly disclosed.
Directors' Remuneration
| Name | Fees | Other | Superannuation | Total FY2026 | Total FY2025 |
|---|---|---|---|---|---|
Alex Waislitz | 0 | 0 | 0 | 0 | 0 |
Alan Fisher | 50,000 | 0 | 6,000 | 56,000 | 55,750 |
Jeremy Leibler (paid to Arnold Bloch Leibler) | 56,000 | 4,605 | 0 | 60,605 | 58,383 |
Martin Casey | 50,000 | 0 | 6,000 | 56,000 | 55,750 |
Tim Birch (retired 17 Nov 2025) | 19,022 | 0 | 2,283 | 21,305 | 55,750 |
Total directors | 175022 | 4605 | 14283 | 193910 | 225633 |
Directors' Remuneration (FY2022–FY2026)
| Manager fees (AUD Mn) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Base fees | 2.85 | 2.10 | 1.67 | 1.61 | 1.37 |
Performance fees | 1.88 | 0.00 | 0.00 | 0.00 | 0.00 |
Total paid to TMS | 4.73 | 2.10 | 1.67 | 1.61 | 1.37 |
Governance Overview
| Attribute | Assessment | Source / basis |
|---|---|---|
Board size | 4 (reduced from 5 after Birch's retirement, Nov 2025) | FY2026 AR |
Chair / CEO separation | No CEO; Chair (Waislitz) controls the Investment Manager — Chair is not independent | FY2026 AR |
Independence (dossier assessment) | Waislitz: not independent (controls manager and 32.75% holder). Casey: not independent in substance (Chief of Staff, Waislitz Family Office). Leibler: independence questionable given his firm is TEK's solicitor and receives his fees. Fisher: appears independent. The Company's own classification is set out in its Corporate Governance Statement | FY2026 AR biographies |
Committees | Audit & Risk Committee (Chair: Alan Fisher; members include Leibler and, from 2 Jul 2026, Casey; all directors invited to attend). Independent Board sub-committee established Feb 2026 to receive the Manager's internal performance review | FY2026 AR; ASX 24 Feb 2026 |
Meetings FY2026 | 6 Board meetings (Waislitz attended 4 of 6; Fisher and Casey 6; Leibler 5); 4 ARC meetings | FY2026 AR |
Gender diversity | All-male board; a shareholder question at the 2025 AGM stated TEK has never had a female director (The Mayne Report, 22 Nov 2025) | The Mayne Report; FY2026 AR |
Governance code | ASX Corporate Governance Principles 4th Edition, "if not, why not"; 2026 statement approved 2 Jul 2026 | FY2026 AR |
Board & Management Changes
| Date | Change | Context | Source |
|---|---|---|---|
8 Nov 2021 | Tim Birch appointed | Added operating technology expertise | FY2022 AR |
17 Nov 2025 | Tim Birch retired at AGM | Not replaced; board reduced to four | FY2026 AR |
24 Feb 2026 | Independent Board sub-committee formed | Review of Manager performance and NTA discount | ASX 24 Feb 2026 |
2 Jul 2026 | Martin Casey appointed to Audit & Risk Committee | Backfills committee after Birch's departure | FY2026 AR |
Major Shareholders
| Rank | Holder | Shares | % issued capital |
|---|---|---|---|
| 1 | Thorney Holdings Proprietary Limited | 100,295,195 | 27.92 |
| 2 | Rubino Group Pty Ltd (Rubino Group A/C) | 40,532,667 | 11.28 |
| 3 | Mutual Trust Pty Ltd | 34,539,775 | 9.61 |
| 4 | Tiga Trading Pty Ltd | 11,720,494 | 3.26 |
| 5 | Venn Milner Superannuation P/L | 10,000,000 | 2.78 |
| 6 | Citicorp Nominees Pty Limited | 7,192,223 | 2.00 |
| 7 | Ace Property Holdings Pty Ltd | 6,500,000 | 1.81 |
| 8 | Crathre Pty Ltd | 4,579,000 | 1.27 |
| 9 | Tamit Nominees Pty Ltd (Itescu Family A/C) | 4,545,455 | 1.27 |
| 10 | Thorney Holdings Proprietary Limited (second account) | 4,484,374 | 1.25 |
| 11 | Halcycon Pty Ltd | 4,000,000 | 1.11 |
| 12 | Perpetual Corporate Trust Ltd (Affluence LIC Fund) | 4,000,000 | 1.11 |
| 13 | HSBC Custody Nominees (Australia) Limited | 3,407,663 | 0.95 |
| 14 | Huoncan Super Pty Ltd | 3,223,353 | 0.90 |
| 15 | Netwealth Investments Limited (Wrap Services A/C) | 2,883,409 | 0.80 |
| 16 | The Dwyer Foundation Pty Ltd | 2,726,000 | 0.76 |
| 17 | Mr Robert and Mrs Francine Velletri (S/F A/C) | 2,719,784 | 0.76 |
| 18 | Mr Silvio and Mrs Mette Salom (Salom Super Fund A/C) | 2,700,532 | 0.75 |
| 19 | Mabra Pty Ltd (Mabra Investments A/C) | 2,173,571 | 0.61 |
| 20 | Mr Ian George and Mrs Jane Cooke | 2,000,000 | 0.56 |
Competitive Landscape
Key Competitors
| Competitor | Type | Relevance to TEK | Key comparative data | Source / status |
|---|---|---|---|---|
Bailador Technology Investments (ASX: BTI) | LIC — expansion-stage private tech | Most direct listed peer for private-tech exposure; co-investor in Mosh | Post-tax NTA AUD 1.61/share at 30 Jun 2026; FY2026 NPAT AUD 6.9m; 2.8% post-tax portfolio return; discount 42% at 30 Jun 2026; fee 1.75% of pre-tax NTA; dividend policy 4% of pre-tax NTA | BTI FY2026 results (13 Aug 2026) via SmallCaps, Kalkine, StockWireX |
Thorney Opportunities (ASX: TOP) | LIC — undervalued listed/unlisted equities, same manager | Sister vehicle competing for the same investor base | After-tax NTA 86.7c / pre-tax 93.0c at 31 Jul 2026; price 57.0c; market cap ~AUD 95.6m; pays fully franked dividends; Thorney group holds 35.9% | TOP Jul 2026 NTA report; Stockopedia |
Acorn Capital Investment Fund (ASX: ACQ) | LIC — listed and unlisted micro-caps | Similar listed/unlisted hybrid model | — | — |
WAM Microcap (ASX: WMI) | LIC — listed micro-caps | Competes for small-cap LIC investors | — | — |
Pengana Private Equity Trust (ASX: PE1) | Listed trust — global private equity | Alternative listed private-markets exposure | — | — |
Salter Brothers Emerging Companies (ASX: SB2) | LIC — emerging/tech companies | Tech-focused LIC peer | — | — |
NAOS Emerging Opportunities (ASX: NCC) | LIC — emerging industrials | Small-cap LIC peer | — | — |
Spheria Emerging Companies (ASX: SEC) | LIC — small/micro caps | Small-cap LIC peer | — | — |
CVC Limited (ASX: CVC) | Listed investment house | Listed/unlisted hybrid | — | — |
S&P/ASX All Technology ETF (ATEC) and other tech ETFs | ETF | Low-cost, liquid alternative for Australian tech exposure | — | — |
Private VC managers (e.g., Rampersand, Square Peg, Blackbird) | Unlisted VC | Compete for early-stage deal flow | Not applicable | — |
Peer Comparison FY2026
| Metric | TEK | BTI | TOP |
|---|---|---|---|
Latest post-tax NTA per share (AUD) | 0.207 (30 Sep 2026) | 1.61 (30 Jun 2026) | 0.867 (31 Jul 2026) |
Discount to post-tax NTA (%) | 49 (30 Sep 2026) | 42 (30 Jun 2026) | 34 (31 Jul 2026, calculated) |
FY2026 NPAT (AUD Mn) | -16.41 | 6.90 | — |
FY2026 portfolio return (%) | -15.4 (NTA/share change, after tax) | 2.8 (post-tax) | — |
Base management fee | 1.5% p.a. of gross assets | 1.75% of pre-tax NTA | — |
Dividend | Nil | Policy 4% of pre-tax NTA | Fully franked dividends paid |
Market cap (AUD Mn) | 37.0 | — | ~95.6 |
Recent Developments
Upcoming: * buy-back expiry 13 November 2026; AGM Tuesday 17 November 2026 (FY2026 AR).



